Victoria P Werth Selected Research

Discoid Lupus Erythematosus

1/2017	Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.
8/2011	Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.
3/2009	Lenalidomide for the treatment of resistant discoid lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria P Werth Research Topics

Disease

35	Dermatomyositis (Dermatopolymyositis) 10/2022 - 09/2002
30	Cutaneous Lupus Erythematosus 10/2022 - 09/2002
18	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 04/2011
14	Skin Diseases (Skin Disease) 10/2022 - 12/2002
14	Pemphigus (Pemphigus Vulgaris) 12/2021 - 06/2005
7	Inflammation (Inflammations) 10/2022 - 03/2012
7	Autoimmune Diseases (Autoimmune Disease) 02/2022 - 09/2002
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 12/2007
6	Infections 01/2022 - 07/2008
5	Localized Scleroderma (Morphea) 04/2021 - 12/2009
5	Osteoporosis 04/2021 - 01/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 02/2021 - 01/2006
5	Bullous Pemphigoid (Pemphigoid) 06/2020 - 09/2002
4	Dermatitis 03/2021 - 09/2002
3	Rupture 01/2022 - 01/2020
3	Skin Manifestations 03/2021 - 10/2007
3	Neoplasms (Cancer) 01/2021 - 02/2003
3	Arthritis (Polyarthritis) 01/2018 - 07/2010
3	Discoid Lupus Erythematosus 01/2017 - 03/2009
2	Bites and Stings (Sting) 10/2022 - 01/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2022
2	Neutropenia 01/2022 - 03/2009
2	Rheumatoid Arthritis 12/2021 - 04/2017
2	Body Weight (Weight, Body) 09/2021 - 01/2021
2	Human Influenza (Influenza) 03/2021 - 01/2017
2	Hepatitis 03/2021 - 02/2017
2	Lupus Nephritis 10/2018 - 08/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 10/2016
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2015
2	Exanthema (Rash) 01/2018 - 01/2006
2	Vasculitis (Vasculitides) 01/2018 - 07/2010
2	Herpes Zoster 01/2017 - 11/2016
2	Sarcoidosis (Schaumann Disease) 12/2015 - 05/2013
2	Bone Resorption 12/2007 - 06/2006
2	Erythema Nodosum 07/2007 - 01/2003
2	Congenital Abnormalities (Deformity) 07/2007 - 01/2003
1	Nausea 01/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

17	Antimalarials (Antimalarial Agents)IBA 10/2022 - 07/2005
9	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2022 - 04/2017
9	AutoantibodiesIBA 02/2021 - 09/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2002
8	Pharmaceutical PreparationsIBA 06/2021 - 01/2003
8	GlucocorticoidsIBA 01/2021 - 06/2005
8	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2020 - 09/2002
7	Quinacrine (Mepacrine)IBA 04/2021 - 01/2017
7	Rituximab (Mabthera)FDA Link 01/2021 - 04/2011
7	InterferonsIBA 01/2021 - 09/2013
6	CytokinesIBA 01/2022 - 11/2016
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2006
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 12/2002
5	Monoclonal AntibodiesIBA 01/2019 - 10/2013
5	SteroidsIBA 02/2011 - 06/2005
4	AntibodiesIBA 12/2021 - 08/2012
4	Immunoglobulin A (IgA)IBA 12/2021 - 09/2015
4	Interferon Type IIBA 01/2021 - 01/2017
4	MucinsIBA 01/2018 - 05/2007
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2013 - 06/2005
3	iberdomideIBA 04/2022 - 01/2022
3	CannabinoidsIBA 03/2022 - 11/2017
3	ChromatinIBA 01/2022 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2012
3	Antinuclear AntibodiesIBA 11/2019 - 08/2012
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2012 - 03/2011
3	Thalidomide (Thalomid)FDA Link 04/2012 - 01/2003
3	CollagenIBA 02/2011 - 05/2007
3	Diphosphonates (Bisphosphonates)IBA 12/2007 - 01/2006
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2006 - 08/2003
2	lenabasum (ajulemic acid)IBA 10/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Lamin Type B (Lamin B)IBA 01/2022 - 01/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 03/2021 - 01/2019
2	Interleukin-12 (IL 12)IBA 10/2018 - 01/2003
2	anifrolumabIBA 01/2018 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 09/2015
2	Prednisone (Sone)FDA LinkGeneric 03/2017 - 06/2005
2	Prostaglandins AIBA 12/2015 - 05/2013
2	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 02/2003
2	Lenalidomide (CC 5013)FDA Link 04/2012 - 03/2009
2	Hyaluronic Acid (Hyaluronan)IBA 08/2011 - 03/2011
2	Carbon MonoxideIBA 10/2010 - 07/2010
2	Dapsone FDA Link 01/2008 - 06/2005
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2022
1	Biological ProductsIBA 04/2022
1	Ligases (Synthetase)IBA 02/2022
1	Janus Kinase 1IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	rho-Associated KinasesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	VaccinesIBA 01/2022
1	ActomyosinIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	GLPG0634IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 12/2021

Therapy/Procedure

29	Therapeutics 10/2022 - 07/2005
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2006
2	Chemoprevention 01/2018 - 09/2015